Onalespib
Onalespib (AT13387) is an orally available small molecule Hsp90 inhibitor with antineoplastic potential. It disrupts Hsp90's chaperone function, leading to the degradation of client oncoproteins critical for tumor survival. This compound has demonstrated activity in preclinical studies across various cancer models, supporting its investigation in oncology research.
Product Specifications
CAS Number
912999-49-6
Product Name Alternative
AT 13387, AT13387, AT-13387, Onalespib, Onalespib (AT13387), inhibit, HSP, HSP90, Inhibitor, Heat shock proteins
Field of Research
Metabolism Research, Signal Transduction
Purity
98.05% (May vary between batches)
Solubility
DMSO:2.04 mg/mL (4.98 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.44 mM)
Smiles
CC (C) c1cc (C (=O) N2Cc3ccc (CN4CCN (C) CC4) cc3C2) c (O) cc1O
Molecular Formula
C24H31N3O3
Molecular Weight
409.52
References & Citations
Pubmed id
41003947
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fascin-1 (Reed-Sternberg Cell Marker) ; Clone FSCN1/417 (Concentrate)
ELL2P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Recombinant Shewanella baltica Glucans biosynthesis glucosyltransferase H (opgH)